A

Agilent Technologies

Provides eProcurement automation and hosted catalogs

Regional Marketing Program Manager

Full-Time
No salary listed
Expert
Bachelor's, Master's
Mumbai, Maharashtra, India+3 moreMore locations: Yishun, Singapore | Bengaluru, Karnataka, India | New Delhi, Delhi, India
In PersonTravel required 25% of the time.
Growth & MarketingMarketing Generalist & Management

About the job

Requirements
  • A Bachelor's or Master's degree or equivalent is required.
  • Typically, at least 8 years of relevant experience is required for entry to this level.
  • A post-graduate credential, certification, and/or license may be required.
Responsibilities
  • Plan, direct, and coordinate marketing programs and initiatives to support funnel generation and sales for India and South Asia Pacific, focusing on Applied Markets and Industries including food and environmental testing, materials, semiconductors, alternative energy, and applied chemicals.
  • Apply understanding of analytical technologies such as chromatography, mass spectrometry, and spectroscopy.
  • Tailor worldwide marketing programs to meet region-specific customer needs and create region-specific programs.
  • Determine the appropriate marketing tactics mix and own execution of all marketing activities and customer communication in the assigned region or country.
  • Analyze market trends and competitor activities and convert them into tactical marketing and sales programs.
  • Consolidate business metrics, market trends, pricing, customer and technology-related information for business units, and enable communication between business units and sales channels.
  • Identify and develop business opportunities and provide information and support for the sales force.
  • Work with regional or country senior management to align sales and marketing functions to capture business opportunities.
  • Engage with customers to generate new customers and maintain current customers for future sales.
  • Assist the sales force in the sales process as needed.

About the company

A

Agilent Technologies

View
Website

Agilent Technologies provides eProcurement services that help businesses buy supplies more efficiently. It offers a suite of electronic procurement tools that let clients load their pricing into existing purchasing platforms, access a hosted catalog, and complete transactions digitally without paper. The service connects pricing data to clients’ procurement systems, delivers an online catalog, and supports automated, paperless purchasing workflows. This makes purchasing faster and reduces manual steps. Compared with competitors, Agilent emphasizes automation, quick connectivity between pricing, catalogs, and purchasing platforms, and a reliable, scalable experience backed by its broad product range. The company aims to improve client productivity and lower procurement costs, helping customers buy what they need more easily while keeping prices clear and consistent.

Company Size

10,001+

Company Stage

IPO

Headquarters

Santa Clara, California

Founded

1999

Get referred to Agilent Technologies

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • Q3 FY2026 revenue hit $1.88 billion, up 8.1%, and guidance rose to $7.51 billion.
  • China grew 9% and pharma grew 12%, signaling stronger end markets.
  • September 2026 launches, including S540MD and Gen5 AI, expand higher-value digital pathology.

What critics are saying

  • Tariff refunds added 110 basis points to Q3 margin, masking underlying profitability.
  • FY26 restructuring costs and workforce reductions continue through first-quarter 2027.
  • A failed pathology pivot leaves Agilent overexposed to slower instrument cycles and commoditization.

What makes Agilent Technologies unique

  • Agilent combines instruments, software, and consumables across pathology, imaging, and analytics.
  • The June 2026 Biocare Medical acquisition deepens its pathology menu and clinical reach.
  • June 2026 OpenAI and BCG collaboration pushes AI into products, operations, and workflows.

Help us improve and share your feedback! Did you find this helpful?

Benefits

  • Remote Work Options
  • Performance Bonus
  • Stock Options

Growth & Insights and Company News

6 month growth

3%

1 year growth

0%

2 year growth

0%
Yahoo Finance
Oct 29th, 2026
Agilent opens University of Chicago energy materials centre, with $9.0B revenue forecast by 2029

Agilent Technologies and the University of Chicago have launched a Center of Excellence for Energy Materials Research. Announced in October 2026, it will use Agilent's mass spectrometry and atomic spectroscopy tools to study next-generation battery and grid storage materials. The tie-up places Agilent instruments inside a leading research setting, which could deepen the company's role in energy storage workflows. It is unlikely to move near-term margins on its own, but it could lift later demand for services and consumables tied to the instruments. Agilent's narrative projects $9.0 billion in revenue and $2.2 billion in earnings by 2029, assuming 6.9% yearly revenue growth. Earnings are $1.4 billion today. Risks include tariffs and weaker academic and government funding, especially in Europe.

Yahoo Finance
Oct 28th, 2026
Agilent shares surge 54.6% to $177.58, but analysts see three reasons to hold off

Agilent shares have jumped 54.6% in six months to $177.58, helped by solid quarterly results. Analysts at StockStory still advise against buying, citing three concerns. First, sales grew at a compounded annual rate of just 3.7% over five years, below the healthcare sector standard. Second, organic revenue, which excludes acquisitions, divestitures, and currency swings, averaged 4.4% year-on-year growth over two years, slightly behind the sector. Third, return on invested capital fell by an average of 2.2 percentage points a year, which may signal fewer profitable growth opportunities. The stock trades at 26.8× forward price-to-earnings. The analysts call Agilent "not a terrible business" but see no big opportunity now.

Yahoo Finance
Oct 13th, 2026
Agilent to buy digital pathology firm Proscia for $240M in cash

Agilent Technologies Inc. agreed to buy Proscia, a digital pathology software provider, in an all-cash deal valued at $240 million at closing. Proscia's founders could earn up to $30 million more if it meets future performance milestones. Proscia's software connects slide scanners, laboratory systems, and AI tools in one platform. It serves more than 4,000 laboratories, hospitals, and clinics, and 16 of the top 20 pharmaceutical companies. Its trailing twelve-month revenue exceeds $18 million. The companies have worked together since a September 2022 distribution agreement. Agilent expects Proscia's recurring-revenue software to add a high-growth, high-margin business to its pathology portfolio. The deal is subject to customary closing conditions and is expected to close early in Agilent's fiscal year 2027.

Business Wire
Sep 29th, 2026
Agilent launches Gen5 AI cell identification module for BioTek automated imagers

Agilent Technologies has launched the BioTek Gen5 AI cell identification module, a new image analysis software add-on for its BioTek automated imaging systems. The module uses AI-based cell identification and segmentation, eliminating the need for conventional threshold setting or parameter tuning. The technology addresses challenges researchers face with threshold-based segmentation, which requires establishing and optimising analysis parameters for individual experiments. This process can introduce user-dependent variation and create difficulties in high-throughput imaging workflows. The module supports label-free and fluorescence applications, as well as live-cell and kinetic assays commonly used in life science and pharmaceutical research. It integrates with Gen5 software, allowing researchers using compatible BioTek Cytation and Lionheart automated imagers to apply AI-based segmentation within existing workflows. Agilent generated revenue of $6.95 billion in fiscal year 2025 and employs approximately 18,000 people worldwide.

Yahoo Finance
Sep 19th, 2026
Agilent launches 540-slide scanner for pathology labs eyeing AI workflows

Agilent Technologies launched the S540MD slide scanner in the United States on 4 September. The FDA-cleared device can hold up to 540 glass slides at once and targets pathology labs managing high sample volumes and preparing for AI-assisted workflows. The scanner automates routine tasks and integrates with existing laboratory setups. It reached select European markets in January and is now available in Germany, the UK, France, and other European countries alongside the US. Agilent reported revenue of $1.88 billion for the quarter ended 31 July, up 8.1% year-on-year. Non-GAAP earnings per share rose 18%. Management raised full-year non-GAAP earnings guidance to $6.18 to $6.21 per share. The S540MD is a rebadged Hamamatsu NanoZoomer S540MD. Agilent has not disclosed pricing or revenue targets for the product.